Chief Executive Officer and President · Axsome Therapeutics
Herriot Tabuteau
Herriot Tabuteau is the founder, Chief Executive Officer, President and Chairman of the Board of Axsome Therapeutics, which he founded in January 2012. He is also the founder and managing member of Antecip Capital LLC.
Current roles
- Axsome TherapeuticsExecutiveChief Executive Officer and Presidentsince 2012Axsome Therapeutics, DEF 14A proxy statement (2026)
current as of Apr 2026 - Axsome TherapeuticsChairChairman of the Boardsince 2012Axsome Therapeutics, DEF 14A proxy statement (2026)
current as of Apr 2026 - Axsome TherapeuticsFounderFoundersince 2012Axsome Therapeutics, DEF 14A proxy statement (2026)
current as of Apr 2026 - Antecip Capital LLCPartnerManaging membersince 2003Axsome Therapeutics, DEF 14A proxy statement (2026)
current as of Apr 2026 - Antecip Bioventures II LLCPartnerManaging memberAxsome Therapeutics, DEF 14A proxy statement (2026)
current as of Apr 2026 - Antecip Capital LLCFounderFounderAxsome Therapeutics, DEF 14A proxy statement (2026)
current as of Apr 2026
Professional roles only. Each role links to its source; a role is marked current only when a recent official source says so. Spot an error? Email info@blackexecutivebrief.com.